Although light skin types are associated with increased skin cancer risk, a lower incidence of
both melanoma and nonmelanoma skin cancer (NMSC) has been reported in patients with …

Vitiligo is a disease featuring distinct white patches that result from melanocyte destruction.
The overall pathogenesis of vitiligo remains to be elucidated. Nevertheless, considerable …

Vitiligo is a skin disorder with melanocyte destruction and an autoimmune basis. Given the
importance of cytokines in autoimmunity, we aimed to find the cytokine profile of innate and …

Vitiligo is an autoimmune disease where its current treatment strategies are lengthy in
course and do not guarantee complete cure. Tofacitinib citrate (JAK inhibitor) is a potential …

Vogt-Koyanagi-Harada syndrome (VKH) and vitiligo are autoimmune diseases that target
melanocytes. VKH affects several organs such as the skin, hair follicle, eyes, ears, and …

Vitiligo is a pigment‐related disease with a global prevalence of 0.2% to 1.8% associated
with considerable burden on quality of life. The treatment is still a challenge because of …

Interferon gamma (IFNG) plays a key role during Mycobacterium tuberculosis (Mtb) infection,
and several polymorphisms located in its gene are associated with risk of tuberculosis in …

Abstract Interferon-gamma (IFN-γ) plays an integral role in the host immunity against
tuberculosis (TB). The gene encoding IFN-γ is polymorphic and several studies have …

Vitiligo is an acquired skin disorder clinically characterized by the progressive appearance
of white maculae due to a loss of functioning epidermal melanocytes. Studies have shown …

Objective Cytokine storms are central to the development of Epstein–Barr virus‐associated
hemophagocytic lymphohistiocytosis (EBV‐HLH). Previous studies have shown that single …